Comparison

Etalocib European Partner

Item no. TMO-T22358-100mg
Manufacturer TargetMol
CASRN 161172-51-6
Amount 100mg
Category
Type Inhibitors
Specific against other
Smiles O=C(O)C1=CC=CC=C1OC2=CC=CC(OCCCOC3=C(CC)C=C(C4=CC=C(F)C=C4)C(O)=C3)=C2CCC
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias LTR,Leukotriene Receptor,Apoptosis, VML295 , LY293111
Available
Short Description
Etalocib is a novel diaryl ether carboxylic acid derivative, is a selective and potent inhibitor of the lipoxygenase pathway either via antagonism of the leukotriene B4 (LTB4) receptor or directly through 5'-lipoxygenase. It has antineoplastic activities.
Shipping
cool pack
Storage
-20°
Target names or alias
VML295 , LY293111
Molecular Weight
544, 6
Pathway
Immunology/Inflammation|||Apoptosis|||GPCR/G Protein
Target
Leukotriene Receptor|||LTR|||Apoptosis

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close